project id: TCGA-CHOL; case submitter id: TCGA-ZH-A8Y7; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; analyte type id: D; spectrophotometer method: PicoGreen; age at index: 59; days to birth: -21880; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1954; age at diagnosis: 21880; ajcc pathologic m: M1; ajcc pathologic n: N0; ajcc pathologic stage: Stage IVB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 755.0; icd 10 code: C22.1; last known disease status: not reported; morphology: 8160/3; primary diagnosis: Cholangiocarcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Intrahepatic bile duct; synchronous malignancy: Not Reported; tissue or organ of origin: Intrahepatic bile duct; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; days to collection: 77; days to sample procurement: 0; initial weight: 1100.0; portion submitter id: TCGA-ZH-A8Y7-01A-21; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 65.0;